Literature DB >> 9679968

Increased risk of hepatoblastoma among immature children with a lower birth weight.

M Tanimura1, I Matsui, J Abe, H Ikeda, N Kobayashi, M Ohira, M Yokoyama, M Kaneko.   

Abstract

Hepatoblastomas among children with very low birth weights have significantly increased recently, according to the data from the Japan Children's Cancer Registry for the years 1985-1993. We then analyzed more Registry data for 1969-1994 to clarify the possible relationship between low birth weight and hepatoblastoma. The percentage of low birth weights was compared between 543 hepatoblastoma children in the Registry and all live births in Japan in four successive periods during the 26 years from 1969 to 1994, in relation to the given birth year. The percentage of children with birth weights of 1500-1999 g among hepatoblastomas was higher, at 2.94-1.60%, than that among all live births in each of the four periods (0.79-0.92%), and the percentage of children with birth weights of 2000-2499 g was slightly higher. The percentage of children with birth weights of <1500 g and, especially, <1000 g, has increased rapidly among children born after 1988 (1.60 and 6.40%, respectively), when most very low birth weight infants began to survive. Compared with children with a birth weight of 2500 g or more, the relative risks of hepatoblastoma among children with birth weights of <1000, 1000-1499, 1500-1999, and 2000-2499 g were 15.64 (P < 0.001), 2.53 (P = 0.129), 2.71 (P = 0.001), and 1.21 (P = 0.381), respectively, suggesting the lower the birth weight, the higher the risk of hepatoblastoma. There was no association between hepatoblastomas with a low birth weight and either age at diagnosis or congenital malformations or light-for-date weight. The risk of hepatoblastoma for low birth weight children may be inherently high, especially for lower birth weights, and the recent rapid increase may be a result of an increase in the number of more immature infants with a more sensitive liver and also more frequent exposure to risk factors related to perinatal treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9679968

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  [Current status of diagnosis and treatment of hepatoblastoma].

Authors:  Purificación García-Miguel; Manuel López Santamaría
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

2.  Hepatoblastoma: why so many low-birth-weight infants?

Authors:  Thomas L Slovis; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2006-03

3.  Cancer risk among children with very low birth weights.

Authors:  Logan G Spector; Susan E Puumala; Susan E Carozza; Eric J Chow; Erin E Fox; Scott Horel; Kimberly J Johnson; Colleen C McLaughlin; Peggy Reynolds; Julie Von Behren; Beth A Mueller
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

Review 4.  Hepatoblastoma--a rare liver tumor with review of literature.

Authors:  L Purnima Devi; Ritesh Kumar; Akash Handique; Mahendra Kumar
Journal:  J Gastrointest Cancer       Date:  2014-12

5.  What do we know about the etiology of hepatoblastoma?

Authors:  Lucie M Turcotte; Logan G Spector
Journal:  Hepat Oncol       Date:  2013-12-20

6.  Hepatoblastoma modeling in mice places Nrf2 within a cancer field established by mutant β-catenin.

Authors:  Sarah A Comerford; Elizabeth A Hinnant; Yidong Chen; Hima Bansal; Shawn Klapproth; Dinesh Rakheja; Milton J Finegold; Dolores Lopez-Terrada; Kathryn A O'Donnell; Gail E Tomlinson; Robert E Hammer
Journal:  JCI Insight       Date:  2016-10-06

7.  Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group.

Authors:  Susan E Puumala; Julie A Ross; James H Feusner; Gail E Tomlinson; Marcio H Malogolowkin; Mark D Krailo; Logan G Spector
Journal:  Hum Reprod       Date:  2012-04-03       Impact factor: 6.918

8.  Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group.

Authors:  Lucie M Turcotte; Michael K Georgieff; Julie A Ross; James H Feusner; Gail E Tomlinson; Marcio H Malogolowkin; Mark D Krailo; Nicole Miller; Rachel Fonstad; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2014-07-15       Impact factor: 3.167

Review 9.  Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?

Authors:  Graham C Burdge; Karen A Lillycrop; Alan A Jackson
Journal:  Br J Nutr       Date:  2008-12-12       Impact factor: 3.718

10.  Case-control study of birth characteristics and the risk of hepatoblastoma.

Authors:  Julia E Heck; Travis J Meyers; Christina Lombardi; Andrew S Park; Myles Cockburn; Peggy Reynolds; Beate Ritz
Journal:  Cancer Epidemiol       Date:  2013-04-01       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.